Free morning briefing · 07:30 weekdays
The RNS that moves prices, in your inbox before the open.
AI-ranked movers and high-impact RNS across the FTSE 100, 250, SmallCap and AIM — one short email, every market day.
Get the briefing
GSK

GSK plc

GSKLSEUnited KingdomHealthcareDrug Manufacturers - GeneralFTSE 100

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D…more

P/E15.62xP/B4.22xROIC19.4%Dividend yield3.7%
£74.49B
Market Cap
EV: £89.05B
MOM5
QUAL9
VAL5
RSK5
GSK
£74.49B
Market Cap · EV £89.05B

GSK plc

MOM5
QUAL9
VAL5
RSK5

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D…more

Latest RNS from GSK plc

Analyst consensus: Hold

As of 10 Nov 2026, 23 analysts rate GSK plc a Hold, with 30% buy ratings and a mean price target of 2,150p (range 1,455p–3,004p), +12% vs the current price.

Strong buy: 1Buy: 6Hold: 13Sell: 1Strong sell: 2

Full analyst history →

Valuation vs peers

Peer-relative fair value estimate: 1,199p against a current price of 1,894p (-37%), based on EV/EBITDA.

More Healthcare companies